Retraction

Protocatechualdehyde Inhibits the Osteoclast Differentiation of RAW264.7 and BMM Cells by Regulating NF- κ B and MAPK Activity

Citations (9)

9
Total Citations
4
Post-Retraction
(44.4%)
4
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
4 Within 1 year
0 After 2+ years
269 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Protocatechualdehyde inhibits iron overload-induced bone loss by inhibiting inflammation and oxidative stress in senile rats
Zhou-Shan Tao, Xu-Feng Hu, Xing-Jing Wu et al. (5 authors)
International Immunopharmacology
Published: Aug 2024
3 citations
269 days after retraction
In Vitro Insights into the Role of 7,8-Epoxy-11-Sinulariolide Acetate Isolated from Soft Coral Sinularia siaesensis in the Potential Attenuation of Inflammation and Osteoclastogenesis
Lin-Mao Ke, Dan-Dan Yu, Ming‐Zhi Su et al. (5 authors)
Marine Drugs Open Access
Published: Feb 2024
1 citation
82 days after retraction
Coenzyme Q10 prevents RANKL-induced osteoclastogenesis by promoting autophagy via inactivation of the PI3K/AKT/mTOR and MAPK pathways
Delu Zheng, Chenli Cui, Chengsong Ye et al. (8 authors)
Brazilian Journal of Medical and Biological Research Open Access
Published: Jan 2024
4 citations
33 days after retraction
Expanding the therapeutic potential of Salvia miltiorrhiza: a review of its pharmacological applications in musculoskeletal diseases
Zhiqiang Ye, Yuyu Liu, Jintong Song et al. (10 authors)
Frontiers in Pharmacology Open Access
Published: Dec 2023
12 citations
6 days after retraction
Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis
Yang Xu, Dezhi Song, Yuangang Su et al. (12 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Jan 2023
31 citations
320 days before retraction
Retracted: Protocatechualdehyde Inhibits the Osteoclast Differentiation of RAW264.7 and BMM Cells by Regulating NF-<i>κ</i>B and MAPK Activity
BioMed Research International
BioMed Research International Open Access
Published: Jan 2023
332 days before retraction
Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity
Wei Deng, YanBo Huang, HaiShan Li et al. (16 authors)
Frontiers in Pharmacology Open Access
Published: Sep 2022
12 citations
434 days before retraction
Monascin abrogates RANKL-mediated osteoclastogenesis in RAW264.7 cells via regulating MAPKs signaling pathways
Yin Cheng, Haixia Liu, Jing Li et al. (9 authors)
Frontiers in Pharmacology Open Access
Published: Jul 2022
5 citations
502 days before retraction
Quick Stats
Total Citations: 17
Years Since Retraction: 2.0 year
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Sorting protein VPS33B regulates exosomal autocrine signali…
The Journal of Clinical Investigation (JCI) • 74 citations
Expression of HIF-1α in keloids and its correlation with in…
European Journal of Inflammation • 1 citations
MZF1 alleviates oxidative stress and apoptosis induced by r…
The Journal of Toxicological Sciences • 12 citations
Protective effect of metformin on rat diabetic retinopathy …
International Immunopharmacology • 38 citations